Your browser doesn't support javascript.
loading
Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study-IMEA 055.
Bachelard, Antoine; Isernia, Valentina; Charpentier, Charlotte; Benalycherif, Aida; Mora, Marion; Donadille, Cécile; Duvivier, Claudine; Lacombe, Karine; El Mouhebb, Mayssam; Spire, Bruno; Landman, Roland; Descamps, Diane; Peytavin, Gilles; Assoumou, Lambert; Ghosn, Jade.
Afiliação
  • Bachelard A; AP-HP Nord, Department of Infectious and Tropical Diseases, Bichat Claude-Bernard University Hospital, Paris, France.
  • Isernia V; AP-HP Nord, Department of Infectious and Tropical Diseases, Bichat Claude-Bernard University Hospital, Paris, France.
  • Charpentier C; Université Paris Cité, INSERM-UMR 1137, IAME, Paris, France.
  • Benalycherif A; AP-HP Nord, Virology Laboratory, Bichat Claude-Bernard University Hospital, Paris, France.
  • Mora M; IMEA, Bichat Claude-Bernard University Hospital, Paris, France.
  • Donadille C; INSERM, IRD, SESSTIM, ISSPAM, Aix Marseille University, Marseille, France.
  • Duvivier C; INSERM, IRD, SESSTIM, ISSPAM, Aix Marseille University, Marseille, France.
  • Lacombe K; AP-HP-Necker Hospital, Infectious Diseases Department, Necker-Pasteur Infectiology Center; IHU Imagine; University Paris Cité, INSERM U1016, CNRS UMR8104, Institut Cochin; Institut Pasteur, Institut Pasteur Medical Center, Paris, France.
  • El Mouhebb M; AP-HP, Hospital Saint-Antoine, Infectious and Tropical Diseases, Paris, France.
  • Spire B; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, F75013, Paris, France.
  • Landman R; INSERM, IRD, SESSTIM, ISSPAM, Aix Marseille University, Marseille, France.
  • Descamps D; AP-HP Nord, Department of Infectious and Tropical Diseases, Bichat Claude-Bernard University Hospital, Paris, France.
  • Peytavin G; Université Paris Cité, INSERM-UMR 1137, IAME, Paris, France.
  • Assoumou L; IMEA, Bichat Claude-Bernard University Hospital, Paris, France.
  • Ghosn J; Université Paris Cité, INSERM-UMR 1137, IAME, Paris, France.
J Antimicrob Chemother ; 78(3): 769-778, 2023 03 02.
Article em En | MEDLINE | ID: mdl-36659824
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França